Please see below all current neuro-oncology clinical trials of the Central Coast Cancer Centre.
Name: MAGMA
The Multi-Arm GlioblastoMa Australasia (MAGMA) Trial is a platform trial that will assess a number of options in standard of care for the management of glioblastoma. Initial questions of interest are: QUESTION 1 whether or not to give a cycle of temozolomide prior to chemoradiotherapy and QUESTION 2: whether to give 6 or 12 cycles of temozolomide after chemoradiotherapy.
Principal Investigator: Dr Malmaruha Arasaratnam
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Brain Cancer
More information about MAGMA
Name: NUTMEG
A Randomized Phase II Open Label Study of Nivolumab and temozolomide vs Temozolomide in Newly Diagnosed Older Subjects with Methylated MGMT (tumor O-6-methylguanine DNA methyltransferase) Glioblastoma.
Principal Investigator: Dr Matthew Wong
Study Coordinator: Richard Clayton
Status: Closed
Condition: Glioblastoma
More information about NUTMEG
More information
For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 9890 or see:
Research and Clinical Trials